These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2921218)

  • 21. [Effect of oleandomycin on the growth of the producer Streptomyces antibioticus itself and on its antibiotic synthesis].
    Virina AM; Kutsenko NN; Belousova II
    Antibiot Med Biotekhnol; 1986 Dec; 31(12):889-92. PubMed ID: 3551816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A mutant of Streptococcus pyogenes 56188 highly resistant to macrolide antibiotics and lincomycin].
    Malke H
    Zentralbl Bakteriol Orig A; 1972 Dec; 222(4):459-67. PubMed ID: 4145163
    [No Abstract]   [Full Text] [Related]  

  • 23. The macrolide group of antibiotics. Mode of action.
    Schmid EE
    Antibiot Chemother (1971); 1971; 17():52-66. PubMed ID: 4951002
    [No Abstract]   [Full Text] [Related]  

  • 24. Neisseria gonorrhoeae-sensitivity to penicillin, erythromycin, tetracycline and streptomycin.
    Hejzlar M; Vymola F
    J Hyg Epidemiol Microbiol Immunol; 1965; 9(3):300-9. PubMed ID: 4955696
    [No Abstract]   [Full Text] [Related]  

  • 25. Microbial transformation of antibiotics. III. Reacylation of 4"-depropionyl maridomycin III into maridomycin V (maridomycin K) by Streptomyces sp. strain no. K-342.
    Uyeda M; Mori S; Morita M; Ogata T; Mori M; Shibata M
    J Antibiot (Tokyo); 1977 Dec; 30(12):1130-1. PubMed ID: 599088
    [No Abstract]   [Full Text] [Related]  

  • 26. New cirramycin-family antibiotics F-1 and F-2. Selection of producer mutants, fermentation, isolation, structural elucidation and antibacterial activity.
    Sawada Y; Tsuno T; Miyaki T; Naito T; Oki T
    J Antibiot (Tokyo); 1989 Feb; 42(2):242-53. PubMed ID: 2925516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbomycin, a macrolide antibiotic.
    Ashy MA; Khalil AE; Abou-Zeid AA
    Zentralbl Bakteriol Naturwiss; 1980; 135(6):541-51. PubMed ID: 7006261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of rythromycin on the growth of "dissociated resistant" Staph. aureus in bacteriostasis from another macrolide or a related antibiotic].
    Bourse R; Monnier J
    Ann Inst Pasteur (Paris); 1967 Jul; 113(1):67-79. PubMed ID: 6079710
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzymic inactivation of lincosaminide and macrolide antibiotics: divalent metal cation and coenzyme specificities.
    Marshall VP; Liggett WF; Cialdella JI
    J Antibiot (Tokyo); 1989 May; 42(5):826-30. PubMed ID: 2722691
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological conversion of erythronolide B, an intermediate of erythromycin biogenesis, into new "hybrid" macrolide antibiotics.
    Spagnoli R; Cappelletti L; Toscano L
    J Antibiot (Tokyo); 1983 Apr; 36(4):365-75. PubMed ID: 6343328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fluometric determination of histamine upon the administration of macrolide antibiotics.
    Yamada S; Wakabayashi K
    J Antibiot (Tokyo); 1974 Oct; 27(10):788-92. PubMed ID: 4457526
    [No Abstract]   [Full Text] [Related]  

  • 32. CV-1, a new antibiotic produced by a strain of Streptomyces sp. I. Fermentation, isolation and biological properties of the antibiotic.
    Ichimura M; Koguchi T; Yasuzawa T; Tomita F
    J Antibiot (Tokyo); 1987 Jun; 40(6):723-6. PubMed ID: 3301772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. I. Microbial deepoxidation and subsequent isomerization of deltamycins A1, A2, A3, A4 (carbomycin A) and X.
    Fukagawa Y; Mutoh Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1984 Feb; 37(2):118-26. PubMed ID: 6706847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methicillin-resistant staphylococci.
    Kayser FH; Mak TM
    Am J Med Sci; 1972 Sep; 264(3):197-205. PubMed ID: 4486503
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of antibiotics on mycoplasma.
    Hoshino Y; Maekawa T; Umezawa I; Hata T
    J Antibiot (Tokyo); 1970 Nov; 23(11):531-6. PubMed ID: 4321093
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sensitivity of Streptomyces globisporus 3-1--a highly active producer of landomycin E to its own and the other polyketide antibiotics].
    Tymchyk OV; Matseliukh BP; Lavrinchuk VIa
    Mikrobiol Z; 2004; 66(2):69-73. PubMed ID: 15208856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis.
    Omura S; Sadakane N; Tanaka Y; Matsubara H
    J Antibiot (Tokyo); 1983 Jul; 36(7):927-30. PubMed ID: 6860432
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New tylosin analogs produced by mutants of Streptomyces fradiae.
    Kiyoshima K; Takada K; Yamamoto M; Kubo K; Okamoto R; Fukagawa Y; Ishikura T; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1987 Aug; 40(8):1123-30. PubMed ID: 3680024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of midecamycin, a new macrolide antibiotic.
    Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
    G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.